More about

Tobramycin

News
May 10, 2023
4 min read
Save

Tobramycin inhalation solution safe for bronchiectasis with Pseudomonas aeruginosa

Adults with bronchiectasis and a Pseudomonas aeruginosa infection had lower bacterial density and better quality of life when treated with tobramycin inhalation solution, according to study results published in CHEST.

News
April 01, 2021
4 min read
Save

Man presents with blurry vision, discomfort after contact lens use

A 70-year-old man presented to the New England Eye Center with 1 day of blurry vision in the right eye, as well as a feeling of dryness and slight discomfort. He reported a history of contact lens use only in the right eye.

News
October 08, 2020
2 min read
Save

IV antibiotics not superior to oral therapy for eradicating P. aeruginosa in cystic fibrosis

Treatment with IV antibiotics, compared with oral therapy, did not achieve sustained eradication of Pseudomonas aeruginosa in a greater proportion of patients with cystic fibrosis, according to results of the TORPEDO-CF trial.

News
September 25, 2020
1 min read
Save

Tobramycin inhalation solution a treatment option for non-cystic fibrosis bronchiectasis

In the BATTLE trial, patients with non-cystic fibrosis bronchiectasis assigned tobramycin inhalation solution once daily had a nonsignificant decrease in number of exacerbations compared with placebo.

News
October 17, 2019
1 min read
Save

Eyevance acquires Tobradex ST, Natacyn

Eyevance Pharmaceuticals has acquired Tobradex ST and Natacyn from Novartis, according to a press release.